Pharmacokinetic and tissue distribution of paclitaxel in rabbits assayed by LC-UV after intravenous administration of its novel liposomal formulation

Biomedical Chromatography

Volumn 28, Issue 2, 2014, Pages 204-212

  Wei, Yumeng ^a   Xue, Zhengkai ^b   Ye, Yun ^a   Wang, Peng ^a   Huang, Yu ^a   Zhao, Ling ^a  

^a Luzhou Medical University   (China)

^b Luzhou Vocational and Technical College   (China)

Author keywords

Bio distribution; LC UV; Novel lung targeting liposomes; Paclitaxel; Pharmacokinetics

Indexed keywords

ACETONITRILE; ASSAYS; BIOLOGICAL ORGANS; EXTRACTION; FREEZING; HISTOLOGY; LIPOSOMES; PHARMACOKINETICS;

AMMONIUM ACETATE; BIODISTRIBUTIONS; EXTRACTION RECOVERY; INTRAVENOUS ADMINISTRATION; LC-UV; LIPOSOMAL FORMULATION; NOVEL LUNG TARGETING LIPOSOME; PACLITAXEL; SIMPLE++; TISSUE DISTRIBUTIONS;

TISSUE;

ACETONITRILE; AMMONIUM ACETATE; DOCETAXEL; LIPOSOME; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; DRUG ISOLATION; DRUG TISSUE LEVEL; EXPERIMENTAL RABBIT; FLOW RATE; FREEZE THAWING; HEART; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIPOSOMAL DELIVERY; LIQUID CHROMATOGRAPHY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; NONHUMAN; SINGLE DRUG DOSE; TISSUE DISTRIBUTION; ULTRAVIOLET SPECTROSCOPY;

ORYCTOLAGUS CUNICULUS;

BIO-DISTRIBUTION; LC-UV; NOVEL LUNG TARGETING LIPOSOMES; PACLITAXEL; PHARMACOKINETICS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; LINEAR MODELS; LIPOSOMES; PACLITAXEL; RABBITS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 84892371957     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3005     Document Type: Article

References (34)

1. Beijnen JH, Hendrikx JJMA, Hillebrand MJX, Thijssen B, Rosing H, Schinkel AH and Schellens JHM. A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2011; 879: 2984-2990.
2. Bulitta JB, Zhao P, Arnold RD, Kessler DR, Daifuku R, Pratt J, Luciano G, Hanauske AR and Gelderblom H. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients. Cancer Chemotherapy and Pharmacy 2009; 63: 1049-1063.
3. Crosasso P, Ceruti MO, Brusa P, Arpicco S, Dosio F and Cattel L. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. Journal of Controlled Release 2000; 63: 19-30.
4. Dilnawaz F, Singh A, Mewar S, Sharma U, Jagannathan NR and Sahoo SK. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model. Biomaterials 2012; 33: 2936-2951.
5. Fetterly GJ and Straubinger RM. Pharmacokinetics of paclitaxel-containing liposomes in rats. AAPS PharmScience 2003; 5: 1-11.
6. Gardner ER, Dahut W and Figg WD. Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2008; 862: 213-218.
7. Green H, Vretenbrant K, Norlander B and Peterson C. Measurement of paclitaxel and its metabolites in human plasma using liquid chromatography/ion trap mass spectrometry with a sonic spray ionization interface. Rapid Communications in Mass Spectrometry 2006; 20: 183-2189.
8. Grobosch T, Schwarze B, Stoecklein D and Binscheck T. Fatal poisoning with Taxus baccata: quantification of paclitaxel (taxol A), 10-deacetyltaxol, baccatin III, 10-deacetylbaccatin III, cephalomannine (taxol B), and 3, 5-dimethoxyphenol in body fluids by liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology 2012; 36: 36-43.
9. Hou L, Yao J and Zhou JP. Simultaneous LC-MS analysis of paclitaxel and retinoic acid in plasma and tissues from tumor-bearing mice. Chromatographia 2011; 73: 471-480.
10. Huo M, Zhang Y, Zhou J, Zou A, Yu D, Wu Y, Li J and Li H. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. International Journal of Pharmaceutics 2010; 394: 162-173.
11. Jiang SG, Zu YG and Zhang L. Determination of a hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel in rat plasma by LC-MS/MS. Biomedical Chromatography 2009; 23: 472-479.
12. Kim JH, Kim YS, Kim S, Park JH, Kim K, Choi K, Chung H, Jeong SY, Park RW, Kim IS and Kwon IC. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. Journal of Controlled Release 2006; 111: 228-234.
13. Kotwani RN, Gokhale PC, Bodhe PV, Kirodian BG, Kshirsagar NA and Pandya SK. A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children, and neonates. International Journal of Pharmacy 2002; 238: 11-15.
14. Liggins RT and Burt HM. Paclitaxel-loaded poly (l-lactic acid) microspheres: blending low and high molecular weight polymers to control morphology and drug release. International Journal of Pharmacy 2004; 282: 61-71.
15. Liu J, Li H, Jiang X, Zhang C and Ping Q. Novel pH-sensitive chitosan-derived micelles loaded with paclitaxel. Carbohydrates and Polymers 2010; 82: 432-439.
16. Liu J, Li HG, Chen DQ, Jin X, Zhao XL, Zhang C and Ping QE. In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel. Drug Delivery 2011; 18: 181-189.
17. Mittal A, Chitkara D and Kumar N. HPLC method for the determination of carboplatin and paclitaxel with cremophorEL in an amphiphilic polymer matrix. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2007; 855: 211-219.
18. Mowafy H, Alanazi F, Alsarra I, Maghraby G and Mohsin K. HPLC method for determination of paclitaxel in rabbit plasma. Asian Journal of Chemistry 2012; 24: 3352-3356.
19. NageswaraRao R, SatyanarayanaRaju S, MastanVali R, Sarma VUM and GirijaSankar G. LC-ESI-MS/MS determination of paclitaxel on dried blood spots. Biomedical Chromatography 2012; 26: 616-621.
20. Sawant RR, Vaze O, Rockwell K and Torchilin VP. Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery. European Journal of Pharmacy and Biopharmacy 2010; 75: 321-326.
21. Singla AK, Garg A and Aggarwal D. Paclitaxel and its formulations. International Journal of Pharmacy 2002; 235: 179-192.
22. Sonnichsen DS and Relling MV. Clinical pharmacokinetics of paclitaxel. Clinical Pharmacokinetics 1994; 27: 256-69.
23. Suno M, Ono T, Iida S, Umetsu N, Ohtaki K, Yamada T, Awaya T, Satomi M, Tasaki Y, Shimizu K and Matsubara K. Improved high-performance liquid chromatographic detection of paclitaxel in patient's plasma using solid-phase extraction, and semi-micro-bore C18 separation and UV detection. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2007; 860: 141-144.
24. Tan Y, Zhou JP, Tong XY and Feng F. LC-MS/MS for determination of paclitaxel in rat tissues: application to a biodistribution study of paclitaxel nanoliposome modified by PEO-PPO-PEO triblock copolymers. Analytical Letters 2006; 39: 1349-1363.
25. The Pharmacopoeia Commission of PRC. The Pharmacopoeia of the People's Republic of China, Part II. 2010, pp. Appendix 194.
26. Van Vlerken LE, Duan ZF, Little SR, Seiden MV and Amiji MM. Biodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model. Molecular Pharmacy 2008; 5: 516-526.
27. Wang LZ, Ho PC, Lee HS, Vaddi HK, Chan YW and Yung CS. Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay. Journal of Pharmaceutical Biomedicine 2003; 31: 283-289.
28. Wang YJ, Wang C, Gong CY, Wang YJ, Guo G, Luo F and Qian ZY. Polysorbate 80 coated poly (-caprolactone)-poly (ethylene glycol)-poly (-caprolactone) micelles for paclitaxel delivery. International Journal of Pharmacy 2012; 434: 1-8.
29. Yang T, Choi MK, Cui FD, Kim JS, Chung SJ, Shim CK and Kim DD. Preparation and evaluation of paclitaxelloadedPEGylated immunoliposome. Journal of Controlled Release 2007; 120: 169-177.
30. Zhang SQ, Song YN and He X. Liquid chromatography-tandem mass spectrometry for the determination of paclitaxel in rat plasma after intravenous administration of poly (l-glutamic acid)-alanine-paclitaxel conjugate. Journal of Pharmaceutical Biomedicine 2010a; 51: 1169-1174.
31. Zhang W, Dutschman GE, Li X and Cheng YC. Quantitation of paclitaxel and its two major metabolites using a liquid chromatography-electrospray ionization tandem mass spectrometry. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2011; 879: 2018-2022.
32. Zhang XK, Sun P, Bi R, Wang JP, Zhang N and Huang GH. Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation. Journal of Drug Targets 2009; 17: 399-407.
33. Zhang Y, Tang L, Sun L, Bao J, Song C, Huang L, Liu K, Tian Y, Tian G, Li Z, Sun H and Mei L. A novel paclitaxel-loaded poly(epsilon-caprolactone)/poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomaterialia 2010b; 6: 2045-2052.
34. Zhu C, Jung S, Luo S, Meng F, Zhu X, Park TG and Zhong Z. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA--PCLPDM AEMA triblock copolymers. Biomaterials 2010; 31: 2408-2416.